The Corporate Wellness Conference Announces BioSphere Medical as a Silver Sponsor
West Palm Beach, FL, September 29, 2009 --(PR.com)-- The Corporate Wellness Conference would like to announce BioSphere Medical as a Silver Sponsor of the 1st Corporate Wellness Conference on October 27th and 28th, 2009.
In November 2002, BioSphere Medical, Inc. received 510(k) clearance from the Food and Drug Administration, or FDA, to market their Embosphere® Microspheres for Uterine Fibroid Embolization (UFE). They were the first company to gain regulatory clearance to market a product for UFE in the United States. They have continued to focus on seeking to grow their Embosphere Microsphere business through their ASK4UFE® awareness and education program and through physician training, Ask4ufe.com
Fibroids are a Common Medical Condition
Uterine fibroids are benign (non-cancerous) tumors that grow on or within the muscle tissue of the uterus. Approximately 20-40% of women 35 years and older have fibroid tumors. Fibroids are more common among women of African-American descent. Some statistics indicate that up to 80% of African-American women will develop uterine fibroids.
Why They Matter To the Workplace
While some women do not experience any of the symptoms of fibroids, the location and size of fibroid tumors can cause symptoms that can affect a woman's quality of life…and their productivity at work. Women suffering from fibroids may be taking several days off per month to cope with symptoms that include pain, fatigue and heavy menstrual bleeding.
Searching for Solutions
More than 5 million women in the U.S. have symptomatic fibroids, yet only 300,000 of them have surgery each year. That means there are millions of women living with symptoms – often because they believe surgery is their only option after medical therapy. Many employees may be suffering in silence, under-treating their symptoms or not doing anything about them, rather than deal with extended hospitalization and time away from work and family. And many object to a hysterectomy – even a laparoscopic or robotic procedure – because they fear a loss of womanhood or early onset of menopause.
A Safe and Effective Alternative
Uterine fibroid embolization (UFE) offers employees another option. The American College of Obstetrics & Gynecology (ACOG) recommends UFE as a safe and effective alternative to surgery for appropriate patients based upon Level A evidence.1 UFE is a non-surgical treatment for symptomatic uterine fibroids performed by a specialist known as an interventional radiologist. Using a catheter and guide wire, the physician injects tiny microspheres into the vessels that feed the fibroids, blocking the blood supply and relieving symptoms.
1 ACOG Practice Bulletin #96, Obtetrics & Gynecology, Vol. 112, No. 2, Part 1, August, 2008.
The Corporate Wellness Conference, CorporateWellnessConference.com, takes place October 27th and 28th, 2009 in Los Angeles, California and will feature up to 400 high level executives in the corporate wellness area, over 20 sponsors, and over 50 expert speakers. The conference will feature key speakers from Pepsi, Intel, Jack in the Box, Caterpillar Inc., Centers for Disease Control, the USDA, the National Institutes of Health and many more employers, and government officials. This will be the first employer focused corporate wellness conference that features private one-on-one networking meetings. Attendees will be able to pre-schedule private one-on-one networking meetings. The Corporate Wellness Conference is the first conference focused on employers and is the official conference of Corporate Wellness Magazine, CorporateWellnessMagazine.com, and the Health and Wellness Association, HealthandWellnessAssociation.com.
Come learn from the leading employers, benefit managers and health plans that have implemented corporate wellness programs with success and amazing results. The educational panel sessions will focus on employers and health plans that have significantly reduced healthcare costs and created change in their employees and the way the employee lives their lives and purchases and utilizes healthcare benefits.
Find out what practical solutions you can implement that really work, and what concepts simply have failed.
This is the one conference per year you can’t afford to miss.
###
In November 2002, BioSphere Medical, Inc. received 510(k) clearance from the Food and Drug Administration, or FDA, to market their Embosphere® Microspheres for Uterine Fibroid Embolization (UFE). They were the first company to gain regulatory clearance to market a product for UFE in the United States. They have continued to focus on seeking to grow their Embosphere Microsphere business through their ASK4UFE® awareness and education program and through physician training, Ask4ufe.com
Fibroids are a Common Medical Condition
Uterine fibroids are benign (non-cancerous) tumors that grow on or within the muscle tissue of the uterus. Approximately 20-40% of women 35 years and older have fibroid tumors. Fibroids are more common among women of African-American descent. Some statistics indicate that up to 80% of African-American women will develop uterine fibroids.
Why They Matter To the Workplace
While some women do not experience any of the symptoms of fibroids, the location and size of fibroid tumors can cause symptoms that can affect a woman's quality of life…and their productivity at work. Women suffering from fibroids may be taking several days off per month to cope with symptoms that include pain, fatigue and heavy menstrual bleeding.
Searching for Solutions
More than 5 million women in the U.S. have symptomatic fibroids, yet only 300,000 of them have surgery each year. That means there are millions of women living with symptoms – often because they believe surgery is their only option after medical therapy. Many employees may be suffering in silence, under-treating their symptoms or not doing anything about them, rather than deal with extended hospitalization and time away from work and family. And many object to a hysterectomy – even a laparoscopic or robotic procedure – because they fear a loss of womanhood or early onset of menopause.
A Safe and Effective Alternative
Uterine fibroid embolization (UFE) offers employees another option. The American College of Obstetrics & Gynecology (ACOG) recommends UFE as a safe and effective alternative to surgery for appropriate patients based upon Level A evidence.1 UFE is a non-surgical treatment for symptomatic uterine fibroids performed by a specialist known as an interventional radiologist. Using a catheter and guide wire, the physician injects tiny microspheres into the vessels that feed the fibroids, blocking the blood supply and relieving symptoms.
1 ACOG Practice Bulletin #96, Obtetrics & Gynecology, Vol. 112, No. 2, Part 1, August, 2008.
The Corporate Wellness Conference, CorporateWellnessConference.com, takes place October 27th and 28th, 2009 in Los Angeles, California and will feature up to 400 high level executives in the corporate wellness area, over 20 sponsors, and over 50 expert speakers. The conference will feature key speakers from Pepsi, Intel, Jack in the Box, Caterpillar Inc., Centers for Disease Control, the USDA, the National Institutes of Health and many more employers, and government officials. This will be the first employer focused corporate wellness conference that features private one-on-one networking meetings. Attendees will be able to pre-schedule private one-on-one networking meetings. The Corporate Wellness Conference is the first conference focused on employers and is the official conference of Corporate Wellness Magazine, CorporateWellnessMagazine.com, and the Health and Wellness Association, HealthandWellnessAssociation.com.
Come learn from the leading employers, benefit managers and health plans that have implemented corporate wellness programs with success and amazing results. The educational panel sessions will focus on employers and health plans that have significantly reduced healthcare costs and created change in their employees and the way the employee lives their lives and purchases and utilizes healthcare benefits.
Find out what practical solutions you can implement that really work, and what concepts simply have failed.
This is the one conference per year you can’t afford to miss.
###
Contact
Corporate Wellness Conference
Anna Konger
561-204-3676
www.corporatewellnessconference.com
Anna Konger
561-204-3676
www.corporatewellnessconference.com
Contact
Categories